Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Join Prof. Linda Mellbin, Prof. Francesco Cosentino and Prof. Lars Rydén.
Free for everyone
This webinar is produced in the framework of the EAPC Diabetes & CVD Educational Programme. Experts from the European Association of Preventive Cardiology (EAPC), European Association for the Study of Diabetes (EASD) Study Group on Diabetes & CVD, ESC Council for Cardiology Practice (CCP), Association of Cardiovascular Nursing and Allied Professions (ACNAP), ESC Working Group on Aorta and Peripheral Vascular Disease, ESC Working Group on Myocardial & Pericardial Diseases, ESC Working Group on Thrombosis are involved in all stages of the programme development.
After watching this webinar, participants will be able to:
Measure your knowledge gain with the pre and post evaluation.
Professor Linda Mellbin, FESCKarolinska InstitutetStockholm, Sweden
Professor Francesco Cosentino, FESCUniversity of GlasgowBHF Glasgow Cardiovascular Research CentreGlasgow, United Kingdom
Professor Lars Rydén, FESCKarolinska InstitutetStockholm, Sweden
This webinar addresses general cardiologists but also cardiologists wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).
This educational programme is accredited for 1 CME Credit(s). Each participant should claim only those hours of credits that have actually been spent in the educational activity.
Find out more about CME and accreditation.
European Society of Cardiology
European Heart HouseLes Templiers2035 Route des CollesCS 80179 Biot
06903, Sophia Antipolis, FR
This programme is supported by Boehringer Ingelheim and Lilly Alliance and Novo Nordisk in the form of an educational grant. The scientific programme has not been influenced in any way by its sponsors.
Our mission: To reduce the burden of cardiovascular disease.
© 2019 European Society of Cardiology. All rights reserved.